| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |